No insurance required · Licensed providers · Free shipping over $150 · Medication delivered to your door
Home › Treatments › Semaglutide
Semaglutide
Weight Loss & GLP-1

Semaglutide

The gold-standard GLP-1 receptor agonist for medically supervised weight loss. Semaglutide mimics the GLP-1 hormone to suppress appetite, slow gastric emptying, and promote steady, sustainable fat loss — prescribed and monitored by licensed providers.

$299/mo
per month · includes provider review
What's included
Get Started → Talk to a Provider

What is Semaglutide?

Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist originally approved for type 2 diabetes management (Ozempic) and later for chronic weight management (Wegovy). It works by mimicking the GLP-1 hormone your body naturally produces after eating.

How It Works

Semaglutide binds to GLP-1 receptors in the brain and pancreas, signaling fullness, slowing digestion, and reducing caloric intake. It also helps stabilize blood sugar levels, preventing the spikes and crashes that drive hunger and cravings.

What to Expect

Most patients experience noticeable appetite reduction within 2–4 weeks. Significant weight loss typically occurs over 3–6 months with consistent use. Your provider will gradually increase your dose to minimize side effects and maximize results.

Important Medical Disclaimer: Semaglutide is a prescription medication and must be prescribed by a licensed provider after a medical evaluation. This product requires a valid prescription from a licensed healthcare provider. Guppy Meds connects patients with independent licensed providers who make all prescribing decisions. This is not a substitute for professional medical advice. Individual results vary. All compounded medications are prepared by a licensed 503(a) compounding pharmacy. These statements have not been evaluated by the Food and Drug Administration.

You Might Also Like

Tirzepatide
Weight Loss & GLP-1
Tirzepatide
Dual GIP/GLP-1 agonist for advanced medically supervised weight loss.
$449
View →
CJC-1295
Peptide Therapy
CJC-1295/Ipamorelin
GHRH analogue that stimulates natural growth hormone production.
$349
View →
PT-141
Sexual Health
PT-141
Peptide that enhances libido and arousal via central mechanisms.
$299
View →

What Our Patients Say

Real experiences from real patients who have transformed their health with Guppy Meds.

★★★★★

“I started semaglutide through Guppy Meds after struggling with weight for over a decade. In 16 weeks I lost 34 pounds and my A1C dropped from 6.1 to 5.4. My provider checked in every step of the way.”

Barbara N.
Semaglutide Patient — 4 months
★★★★★

“The nausea in week two was rough but my provider adjusted my titration schedule immediately when I reached out. By week four I felt great. Now at month six — down 42 pounds.”

Thomas R.
Semaglutide Patient — 6 months
★★★★★

“I compared prices at several telehealth platforms. Guppy Meds was the most affordable, the process was the smoothest, and the compounded semaglutide quality has been excellent.”

Julie M.
Semaglutide Patient — 3 months
34 lbs
Avg Weight Loss (16 wks)
96%
Patient Satisfaction
<24hr
Prescription Turnaround
Free
Shipping on All Orders
Our Standards

Your Safety & Privacy First

We hold ourselves to the highest standards of clinical quality, privacy, and patient care.

✓FDA-Registered Pharmacy
✓Licensed Providers
✓HIPAA Compliant
✓SSL Secured
✓No Insurance Required
✓Same-Day Processing
✓Free Discreet Shipping
✓503(a) Compounding
Clinical Research

What the Research Shows

Semaglutide is one of the most extensively studied weight-loss medications in history.

15%

SCALE Trial

The SCALE Obesity and Prediabetes trial demonstrated an average of 15% body weight reduction over 68 weeks versus placebo. Published in NEJM, 2021.

2.4mg

SUSTAIN Trial

The SUSTAIN series evaluated semaglutide across 8 trials in type 2 diabetes, consistently showing superior HbA1c reduction at the 2.4mg weekly dose compared to all comparators.

20%

SELECT Trial

The SELECT cardiovascular outcomes trial showed a 20% reduction in major adverse cardiovascular events in patients without diabetes, establishing semaglutide's cardioprotective profile.

Eligibility

Who Qualifies for Semaglutide?

Our providers use established clinical criteria to determine candidacy during your intake review.

You May Qualify If:

  • ✓BMI ≥ 27 with at least one weight-related condition
  • ✓BMI ≥ 30 regardless of comorbidities
  • ✓Type 2 diabetes or prediabetes with weight management goals
  • ✓No prior response to diet and exercise alone

Contraindications Include:

  • ✗Type 1 diabetes mellitus
  • ✗Personal or family history of medullary thyroid carcinoma
  • ✗History of pancreatitis
  • ✗Pregnancy or breastfeeding
Treatment Comparison

Semaglutide vs. Tirzepatide

Both are excellent options. Your provider will help determine which is the better fit for your goals.

Semaglutide (GLP-1)

  • →Single receptor agonist (GLP-1 only)
  • →Avg ~15% body weight reduction (SCALE trial)
  • →Strong cardiovascular outcomes data (SELECT)
  • →Well-tolerated; established side-effect profile
  • →Ideal starting point for most patients

Tirzepatide (GLP-1 + GIP)

  • →Dual receptor agonist (GLP-1 + GIP)
  • →Avg ~20–22% body weight reduction (SURMOUNT)
  • →Superior insulin sensitivity improvement
  • →May be preferred for metabolic syndrome
  • →Option for patients who plateau on semaglutide

Medical Disclaimer

The information provided on this website is for educational and informational purposes only and is not intended as medical advice. All treatments require a valid prescription from a licensed medical provider. Individual results may vary. Consult your healthcare provider before beginning any new treatment protocol.